Also known as: Acetyl hexapeptide-8
A topical peptide often called "Botox in a bottle".
Educational reference, not medical advice. Many compounds here are not approved, and products sold as research chemicals are not checked for purity. Plan any use with a licensed clinician.
How it works
Interferes with the SNARE complex that releases the signal for facial muscles to contract.
Evidence by goal
| Goal | Grade | What the grade means |
|---|---|---|
| Skin, hair & appearance | C | Limited human data, case series or practitioner reports |
At a glance
- Route
- Topical
- Half-life
- Not applicable
Reported dosing
Serums with 5 to 10% concentration, twice daily.
Timing: Morning and evening on clean skin.
Cycle: Ongoing; results in 4 weeks.
From approved labels where they exist, otherwise from published trials and practitioner reports.
Side effects
- Mild irritation
Who should avoid it
- None significant
Often combined with
With GHK-Cu serums.
Key findings
Small studies show up to about 30% shallower wrinkles at 10% concentration; much weaker than Botox.
2026 update
"Botox-like" marketing claims are overstated.
Where it is legal (Oct 2026)
| US | No prescription |
|---|---|
| Canada | No prescription |
| Mexico | No prescription |
| EU | No prescription |
Sources
Open Argireline in the Peptide Guide Compare all peptides by goal
Last reviewed November 2026. Regulatory status reflects the US unless noted and changes often.